These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21706830)

  • 21. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
    Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
    Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyneuropathies and chronic inflammatory demyelinating polyradiculoneuropathy in multiple sclerosis.
    Suanprasert N; Taylor BV; Klein CJ; Roforth MM; Karam C; Keegan BM; Dyck PJB
    Mult Scler Relat Disord; 2019 May; 30():284-290. PubMed ID: 30870805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.
    Bromberg MB; Feldman EL; Albers JW
    Neurology; 1992 Jun; 42(6):1157-63. PubMed ID: 1603342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inflammatory demyelinating polyradiculoneuropathy and variants: where we are and where we should go.
    Nobile-Orazio E
    J Peripher Nerv Syst; 2014 Mar; 19(1):2-13. PubMed ID: 24612201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.
    Isoda A; Sakurai A; Ogawa Y; Miyazawa Y; Saito A; Matsumoto M; Sawamura M
    Int J Hematol; 2009 Sep; 90(2):239-242. PubMed ID: 19588217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide for treatment of gastrointestinal bleedings due to angiodysplasia: a case report in acquired von Willebrand syndrome and review of the literature.
    Engelen ET; van Galen KP; Schutgens RE
    Haemophilia; 2015 Jul; 21(4):419-29. PubMed ID: 25929157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients.
    Alkhawajah NM; Dunnigan SK; Bril V
    J Neurol; 2014 Aug; 261(8):1485-91. PubMed ID: 24801490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
    Wadwekar V; Kalita J; Misra UK
    Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease.
    van Genderen PJ; Michiels JJ; Bakker JJ; van 't Veer MB
    Vox Sang; 1994; 67(1):14-7. PubMed ID: 7975445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG kappa monoclonal gammopathy of undetermined significance presenting as acquired type III Von Willebrand syndrome.
    Howard CR; Lin TL; Cunningham MT; Lipe BC
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):631-3. PubMed ID: 24686099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.
    Mathis S; Franques J; Richard L; Vallat JM
    Medicine (Baltimore); 2016 Sep; 95(36):e4807. PubMed ID: 27603395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
    Federici AB
    Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
    Kawaguchi N; Sugeno N; Endo K; Miura E; Misu T; Nakashima I; Itoyama Y
    J Clin Neurosci; 2012 Apr; 19(4):604-5. PubMed ID: 22285114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers.
    Haddad M; Voisin J; Reynes C; Blanc-Jouvan F; Gressin R; Mansard C; Park S; Marlu R
    Thromb Res; 2022 Jan; 209():1-4. PubMed ID: 34826640
    [No Abstract]   [Full Text] [Related]  

  • 36. History, Diagnosis, and Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Dyck PJB; Tracy JA
    Mayo Clin Proc; 2018 Jun; 93(6):777-793. PubMed ID: 29866282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different clinical, electrophysiological and immunological features of CIDP associated with paraproteinaemia.
    Cocito D; Durelli L; Isoardo G
    Acta Neurol Scand; 2003 Oct; 108(4):274-80. PubMed ID: 12956862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic inflammatory demyelinating polyneuropathy (CIDP) revealing an associated disease diagnostic and therapeutic pitfalls].
    Maisonobe T; Jaccard A
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S61-7. PubMed ID: 18087232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.
    Naddaf E; Dispenzieri A; Mandrekar J; Mauermann ML
    Muscle Nerve; 2015 Oct; 52(4):658-9. PubMed ID: 26179010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel paraneoplastic syndrome with acquired lipodystrophy and chronic inflammatory demyelinating polyneuropathy in an adolescent male with craniopharyngioma.
    Lockemer HE; Sumpter KM; Cope-Yokoyama S; Garg A
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):479-483. PubMed ID: 29455190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.